215 related articles for article (PubMed ID: 35876940)
1. The correlation of atrophy, traction and neovascularization in myopic choroidal neovascularization according to a novel myopic maculopathy classification system (atrophy (A), traction (T), neovascularization (N): ATN).
Kurt RA; Sarıgül Sezenöz A; Akkoyun I; Yılmaz G
Int Ophthalmol; 2022 Sep; 42(9):2925-2932. PubMed ID: 35876940
[TBL] [Abstract][Full Text] [Related]
2. CHOROIDAL THICKNESS AND CHORIORETINAL ATROPHY IN MYOPIC CHOROIDAL NEOVASCULARIZATION WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
Lee JH; Lee SC; Kim SH; Koh HJ; Kim SS; Byeon SH; Lee CS
Retina; 2017 Aug; 37(8):1516-1522. PubMed ID: 27798519
[TBL] [Abstract][Full Text] [Related]
3. CHANGES IN MYOPIC MACULOPATHY BASED ON ATN CLASSIFICATION SYSTEM: An Optical Coherence Tomography Angiography Study.
Wang Y; Jiang C; Zhao X; Chen J; Li J; Huang X; Liu B; Lu L
Retina; 2022 Apr; 42(4):679-688. PubMed ID: 35350047
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes.
Kang MT; Wang N; Xu W; Yusufu M; Liu W; Tian J; Qi Y
BMC Ophthalmol; 2024 Mar; 24(1):118. PubMed ID: 38481176
[TBL] [Abstract][Full Text] [Related]
5. Progression of Myopic Maculopathy during 18-Year Follow-up.
Fang Y; Yokoi T; Nagaoka N; Shinohara K; Onishi Y; Ishida T; Yoshida T; Xu X; Jonas JB; Ohno-Matsui K
Ophthalmology; 2018 Jun; 125(6):863-877. PubMed ID: 29371011
[TBL] [Abstract][Full Text] [Related]
6. Choroidal thickness after treatment for myopic
choroidal neovascularization.
Farinha CL; Baltar AS; Nunes SG; Franqueira NF; Figueira JP; Pires IA; Cachulo ML; Silva RM
Eur J Ophthalmol; 2013; 23(6):887-98. PubMed ID: 23787449
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization.
Sayanagi K; Uematsu S; Hara C; Wakabayashi T; Fukushima Y; Sato S; Ikuno Y; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):749-757. PubMed ID: 30643966
[TBL] [Abstract][Full Text] [Related]
8. Progression of myopic maculopathy after treatment of choroidal neovascularization.
Farinha CL; Baltar AS; Nunes SG; Figueira JP; Pires IA; Cachulo ML; Silva RM
Ophthalmologica; 2014; 231(4):211-20. PubMed ID: 24662778
[TBL] [Abstract][Full Text] [Related]
9. Long-term pattern of progression of myopic maculopathy: a natural history study.
Hayashi K; Ohno-Matsui K; Shimada N; Moriyama M; Kojima A; Hayashi W; Yasuzumi K; Nagaoka N; Saka N; Yoshida T; Tokoro T; Mochizuki M
Ophthalmology; 2010 Aug; 117(8):1595-611, 1611.e1-4. PubMed ID: 20207005
[TBL] [Abstract][Full Text] [Related]
10. OCT-Based Diagnostic Criteria for Different Stages of Myopic Maculopathy.
Fang Y; Du R; Nagaoka N; Yokoi T; Shinohara K; Xu X; Takahashi H; Onishi Y; Yoshida T; Ohno-Matsui K
Ophthalmology; 2019 Jul; 126(7):1018-1032. PubMed ID: 30703442
[TBL] [Abstract][Full Text] [Related]
11. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
[TBL] [Abstract][Full Text] [Related]
12. CORRESPONDENCE OF LEAKAGE ON FLUORESCEIN ANGIOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS IN DIAGNOSIS AND MONITORING OF MYOPIC CHOROIDAL NEOVASCULARIZATION TREATED WITH BEVACIZUMAB.
Battaglia Parodi M; Iacono P; Bandello F
Retina; 2016 Jan; 36(1):104-9. PubMed ID: 26166803
[TBL] [Abstract][Full Text] [Related]
13. Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy.
Hayashi K; Ohno-Matsui K; Teramukai S; Shimada N; Moriyama M; Hayashi W; Yoshida T; Tokoro T; Mochizuki M
Am J Ophthalmol; 2009 Sep; 148(3):396-408. PubMed ID: 19427991
[TBL] [Abstract][Full Text] [Related]
14. Macular choroidal volume variations in highly myopic eyes with myopic traction maculopathy and choroidal neovascularization.
Barteselli G; Lee SN; El-Emam S; Hou H; Ma F; Chhablani J; Conner L; Cheng L; Bartsch DU; Freeman WR
Retina; 2014 May; 34(5):880-9. PubMed ID: 24217703
[TBL] [Abstract][Full Text] [Related]
15. Anti-Vascular Endothelial Growth Factor Therapy for Myopic Choroidal Neovascularization.
Ng DSC; Lai TYY; Cheung CMG; Ohno-Matsui K
Asia Pac J Ophthalmol (Phila); 2017; 6(6):554-560. PubMed ID: 29057641
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of myopic choroidal neovascularization: A systematic review and meta-analysis.
Zhang XJ; Chen XN; Tang FY; Szeto S; Ling XT; Lin ZX; Tham CC; Pang CP; Chen LJ; Yam JC
Surv Ophthalmol; 2023; 68(6):1011-1026. PubMed ID: 37517683
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and Treatment of Myopic Maculopathy.
Yokoi T; Ohno-Matsui K
Asia Pac J Ophthalmol (Phila); 2018; 7(6):415-421. PubMed ID: 30255668
[TBL] [Abstract][Full Text] [Related]
18. MORPHOLOGICAL CHARACTERISTICS AND VISUAL ACUITY OF HIGHLY MYOPIC EYES WITH DIFFERENT SEVERITIES OF MYOPIC MACULOPATHY.
Zhao X; Ding X; Lyu C; Li S; Liu B; Li T; Sun L; Zhang A; Lu J; Liang X; Jin C; Lu L
Retina; 2020 Mar; 40(3):461-467. PubMed ID: 30576301
[TBL] [Abstract][Full Text] [Related]
19. Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN).
Ruiz-Medrano J; Montero JA; Flores-Moreno I; Arias L; García-Layana A; Ruiz-Moreno JM
Prog Retin Eye Res; 2019 Mar; 69():80-115. PubMed ID: 30391362
[TBL] [Abstract][Full Text] [Related]
20. Features of optical coherence tomography predictive of choroidal neovascularisation treatment response in pathological myopia in association with fluorescein angiography.
Lee DH; Kang HG; Lee SC; Kim M
Br J Ophthalmol; 2018 Feb; 102(2):238-242. PubMed ID: 28600301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
